Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
Volume 28, Issue 2, Pages 194-200
Publisher
SAGE Publications
Online
2015-04-29
DOI
10.1177/0394632015584502
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exression and PI3K/AKT Pathway in Gastric Cancer and its Blockade Suppresses Tumor Growth and Metastasis
- (2017) B. Ye et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Clinical Significance of HMGB1 Expression in Human Gastric Cancer
- (2017) J. Zhang et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
- (2014) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Expression of p-Akt and COX-2 in Gastric Adenocarcinomas and Adenovirus Mediated Akt1 and COX-2 ShRNA Suppresses SGC-7901 Gastric Adenocarcinoma and U251 Glioma Cell Growth In Vitro and In Vivo
- (2014) Jing Zhang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- CXCL16 and CXCR6 in Ewing sarcoma family tumor
- (2013) Ki Yong Na et al. HUMAN PATHOLOGY
- The CXCL16–CXCR6 chemokine axis in glial tumors
- (2013) Kirsten Hattermann et al. JOURNAL OF NEUROIMMUNOLOGY
- Gastric cancer—molecular and clinical dimensions
- (2013) Roopma Wadhwa et al. Nature Reviews Clinical Oncology
- CXCR6 and CCR5 Localize T Lymphocyte Subsets in Nasopharyngeal Carcinoma
- (2012) Greg Parsonage et al. AMERICAN JOURNAL OF PATHOLOGY
- CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma
- (2012) Q. Gao et al. CANCER RESEARCH
- Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas
- (2012) Ya-nan Xing et al. HUMAN PATHOLOGY
- The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas
- (2012) GU LI et al. ONCOLOGY REPORTS
- Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model
- (2012) JI-YE KEE et al. ONCOLOGY REPORTS
- CXCR6: The Role of Environment in Tumor Progression. Challenges for Therapy
- (2012) Caterina A. M. La Porta Stem Cell Reviews and Reports
- Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer
- (2012) Yu Huang et al. Chinese Journal of Cancer
- Soluble CXCL16 in Preoperative Serum is a Novel Prognostic Marker and Predicts Recurrence of Liver Metastases in Colorectal Cancer Patients
- (2011) Kohei Matsushita et al. ANNALS OF SURGICAL ONCOLOGY
- Expression and localization of CXCL16 and CXCR6 in ovarian endometriotic tissues
- (2011) Shuichi Manabe et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- The expression and role of CXC chemokines in colorectal cancer
- (2011) Hannelien Verbeke et al. CYTOKINE & GROWTH FACTOR REVIEWS
- T Lymphocyte Recruitment into Renal Cell Carcinoma Tissue: A Role for Chemokine Receptors CXCR3, CXCR6, CCR5, and CCR6
- (2011) Kimberley A. Oldham et al. EUROPEAN UROLOGY
- Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma
- (2011) Li Guo et al. Chinese Journal of Cancer
- Enhanced Tumor Metastasis in Response to Blockade of the Chemokine Receptor CXCR6 Is Overcome by NKT Cell Activation
- (2009) R. Cullen et al. JOURNAL OF IMMUNOLOGY
- The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers
- (2009) Merav Darash-Yahana et al. PLoS One
- The Chemokine Receptor CXCR6 and Its Ligand CXCL16 Are Expressed in Carcinomas and Inhibit Proliferation
- (2008) J. Meijer et al. CANCER RESEARCH
- CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway
- (2008) J. Wang et al. CANCER RESEARCH
- CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells
- (2008) Weidong Hu et al. CANCER SCIENCE
- Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients
- (2008) Paul Gutwein et al. EUROPEAN JOURNAL OF CANCER
- Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas
- (2008) Janka Held-Feindt et al. GLIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now